Capital Flow Monitor · Sponsors · CIK 2130748

Terremoto Biosciences, Inc.

230 EAST GRAND AVENUE, SUITE 200, SOUTH SAN FRANCISCO, CA, 94080 · 415-535-2787

Biotechnology · Corporation· inc. DELAWARE true 2022

Fit score

—

Offering

$108.6M

Sold

$40.7M

% sold

37.5%

Investors

14

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-04-22 D ·current 506(b) $108.6M $40.7M 37.5% 14 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.